New pathways emerging in the powering of miniature medical devices

Ilika Plc

For years, the challenge of powering the smallest implanted medical devices has held back the pace of miniaturisation in healthcare technology. Conventional battery formats have dictated both the size and complexity of these devices, limiting how deeply or delicately they can be placed within the body. That constraint is now beginning to dissolve, as Ilika’s solid state battery technology intersects with a novel charging method that turns sound itself into energy.

In collaboration with Piezo Energy Technologies, Ilika has demonstrated how its Stereax solid state batteries can be recharged wirelessly using directed ultrasound. The test scenario mimicked a medical implant recharging inside the body, showing that even at miniature scales, reliable power transfer is achievable through tissue using safe ultrasound fields.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search